All-Oral Therapy Improves PFS vs. Chemoimmunotherapy in Lymphoma Study
A recent treatment combination for chronic lymphocytic leukemia (CLL) has received approval, offering a potentially less disruptive option for patients facing this blood cancer. The U.S. … Read more